FDA NDC Directory · JSON-LD · Markdown
NDC 69097-529 · HUMAN PRESCRIPTION DRUG · FOR SUSPENSION
| Labeler / Manufacturer | Cipla USA Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA211751 |
| Dosage form / route | FOR SUSPENSION · ORAL |
| Active ingredients | ESOMEPRAZOLE MAGNESIUM DIHYDRATE (40 mg/1) |
| Marketing started | 20200324 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).